ETFs Kenvue Inc.

KVUE

US49177J1025

Personal Products

Market Closed - Nyse Other stock markets 04:00:02 2026-03-06 pm EST			Pre-market 08:57:37 am
18.39 ^USD	+0.77%		18.28	-0.60%

Mar. 06	Tylenol use among women dropped after Trump tied it to autism, Lancet analysis shows	RE
Mar. 05	Barclays Adjusts Price Target on Kenvue to $19 From $18, Maintains Equalweight Rating	MT

ETFs positioned on Kenvue Inc.

Name		Varia. Jan 1.	Weight	AuM
HSBC MSCI USA QUALITY UCITS ETF - USD		-0.79%	0.09%	321 M€

Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).

Employees

21,890

Sector

Personal Products

More about the company